188 related articles for article (PubMed ID: 9076713)
21. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
22. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
[TBL] [Abstract][Full Text] [Related]
23. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome.
Lay JD; Tsao CJ; Chen JY; Kadin ME; Su IJ
J Clin Invest; 1997 Oct; 100(8):1969-79. PubMed ID: 9329960
[TBL] [Abstract][Full Text] [Related]
25. A rapid and reliable enzyme immunoassay PCR-based screening method to identify EBV-carrying gastric carcinomas.
van Beek J; zur Hausen A; Kranenbarg EK; Warring RJ; Bloemena E; Craanen ME; van de Velde CJ; Middeldorp JM; Meijer CJ; van den Brule AJ
Mod Pathol; 2002 Aug; 15(8):870-7. PubMed ID: 12181273
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
27. Profiling of Epstein-Barr virus latent RNA expression in clinical specimens by gene-specific multiprimed cDNA synthesis and PCR.
Stevens SJ; Brink AA; Middeldorp JM
Methods Mol Biol; 2005; 292():27-38. PubMed ID: 15507699
[TBL] [Abstract][Full Text] [Related]
28. Induction of Epstein-Barr virus (EBV) reactivation in Raji cells by doxorubicin and cisplatin.
Hsu CH; Hergenhahn M; Chuang SE; Yeh PY; Wu TC; Gao M; Cheng AL
Anticancer Res; 2002; 22(6C):4065-71. PubMed ID: 12553034
[TBL] [Abstract][Full Text] [Related]
29. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC
J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182
[TBL] [Abstract][Full Text] [Related]
30. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells.
Lin CT; Lin CR; Tan GK; Chen W; Dee AN; Chan WY
Am J Pathol; 1997 May; 150(5):1745-56. PubMed ID: 9137098
[TBL] [Abstract][Full Text] [Related]
31. Quantitation of Epstein-Barr virus mRNA using reverse transcription and real-time PCR.
Weinberger B; Plentz A; Weinberger KM; Hahn J; Holler E; Jilg W
J Med Virol; 2004 Dec; 74(4):612-8. PubMed ID: 15484273
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
[TBL] [Abstract][Full Text] [Related]
33. Demonstration of Epstein-Barr virus genomes, using polymerase chain reaction in situ hybridization in paraffin-embedded lymphoid tissues.
Ohshima K; Kikuchi M; Kobari S; Masuda Y; Yoneda S; Takeshita M
Pathol Res Pract; 1995 Mar; 191(2):139-47. PubMed ID: 7567683
[TBL] [Abstract][Full Text] [Related]
34. Detection of Epstein-Barr virus infection and gene expression in human tumors by microarray analysis.
Li C; Chen RS; Hung SK; Lee YT; Yen CY; Lai YW; Teng RH; Huang JY; Tang YC; Tung CP; Wei TT; Shieh B; Liu ST
J Virol Methods; 2006 May; 133(2):158-66. PubMed ID: 16384612
[TBL] [Abstract][Full Text] [Related]
35. Analysis of Epstein-Barr virus gene expression upon phorbol ester and hydroxyurea treatment by real-time quantitative PCR.
Pan YR; Fang CY; Chang YS; Chang HY
Arch Virol; 2005 Apr; 150(4):755-70. PubMed ID: 15785969
[TBL] [Abstract][Full Text] [Related]
36. Determination of Epstein-Barr virus (EBV) load by RT-PCR and cellular dilution.
Orentas RJ
Mol Cell Probes; 1998 Dec; 12(6):427-30. PubMed ID: 9843661
[TBL] [Abstract][Full Text] [Related]
37. [Use of the real-time RT-PCR method for investigation of small stable RNA expression level in human epidermoid carcinoma cells A431].
Nikitina TV; Nazarova NIu; Tishchenko LI; Tuohimaa P; Sedova VM
Tsitologiia; 2003; 45(4):392-402. PubMed ID: 14520871
[TBL] [Abstract][Full Text] [Related]
38. Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells.
Cochet C; Martel-Renoir D; Grunewald V; Bosq J; Cochet G; Schwaab G; Bernaudin JF; Joab I
Virology; 1993 Nov; 197(1):358-65. PubMed ID: 8212572
[TBL] [Abstract][Full Text] [Related]
39. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
40. Strand-Specific rTth RT-PCR for the Analysis of HCV Replication.
Lanford RE; Chavez D
Methods Mol Med; 1999; 19():471-81. PubMed ID: 21374388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]